SBC Medical Group Holdings Inc

SBC Medical Group Holdings Inc (SBC) Stock Analysis

$5.160

-0.136 (-2.64%)At close

Loading chart…
High
5.350
Open
5.300
VWAP
5.21
Volume
119.49K
Mkt Cap
—
Low
5.130
Amount
622.93K
EV/EBITDA, TTM
4.85

SBC Medical Group Holdings Incorporated is a management company, which owns, operates, and provides management services to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including, but not limited to, advertising and marketing needs across various platforms, staff management, booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumable's procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program, and payment tools for the franchisee clinics.

AI analysis of SBC Medical Group Holdings Inc (SBC)

Hold

SBC Medical Group Holdings Inc is currently trading at $5.16, with a forward P/E of 9.33, indicating it may be undervalued compared to its earnings potential. However, the RSI is at 42.19, suggesting it is nearing oversold territory but not yet a strong buy signal. The company reported a gross margin of 73.14% in Q2 2026, which is solid, but the recent 4.80% decline over the last five days raises concerns about short-term volatility. Therefore, while there are positive growth indicators, the recent price drop and lack of strong momentum suggest holding off on buying for now.

Valuation Metrics

The current forward P/E ratio for SBC Medical Group Holdings Inc (SBC) is 9.33, compared to its 5-year average forward P/E of 4.71.

Forward P/E

Overvalued
5Y Average P/E
4.71
Current P/E
9.33
Overvalued
8.69
Undervalued
0.73

Forward EV/EBITDA

Strongly Overvalued
5Y Average EV/EBITDA
1.02
Current EV/EBITDA
4.85
Overvalued
2.63
Undervalued
-0.59

Forward P/S

Overvalued
5Y Average P/S
1.35
Current P/S
2.59
Overvalued
2.46
Undervalued
0.24

Events Timeline

2026-08-13 (ET)

07:00:00

SBC Medical Reports Q2 Revenue of $49M

2026-05-14 (ET)

06:40:00

SBC Medical Reports Q1 Revenue of $43M, Below Expectations

2026-03-27 (ET)

16:30:00

Major Averages Drop Due to Strait of Hormuz Incidents

12:00:00

Major Averages Decline Amid Middle East Tensions

06:50:00

SBC Medical Q4 Revenue at $40M, Below Consensus

News

SBC FAQ — answered by Alphio AI

SBC Medical Group Holdings Incorporated is a management company, which owns, operates, and provides management services to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including, but not limited to, advertising and marketing needs across various platforms, staff management, booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumable's procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program, and payment tools for the franchisee clinics. It operates in the Industrials sector.

SBC Medical Group Holdings Inc is currently trading at $5.16, with a forward P/E of 9.33, indicating it may be undervalued compared to its earnings potential. However, the RSI is at 42.19, suggesting it is nearing oversold territory but not yet a strong buy signal. The company reported a gross margin of 73.14% in Q2 2026, which is solid, but the recent 4.80% decline over the last five days raises concerns about short-term volatility. Therefore, while there are positive growth indicators, the recent price drop and lack of strong momentum suggest holding off on buying for now.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading